Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping

Pharmacogenomics Journal

Volumn 12, Issue 3, 2012, Pages 214-226

  Matsson, P ^a,b   Yee, S W ^a   Markova, S ^a   Morrissey, K ^a   Jenkins, G ^a   Xuan, J ^a   Jorgenson, E ^a   Kroetz, D L ^a   Giacomini, K M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

ATP binding cassette transporters; expression quantitative trait mapping; lymphoblastoid cell lines; population differences; transcriptional regulation

Indexed keywords

ABC TRANSPORTER; MESSENGER RNA;

ABC GENE; AFRICA; ARTICLE; ASIA; EUROPE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; RACE DIFFERENCE; REGULATORY SEQUENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CONTINENTAL POPULATION GROUPS; DATABASES, NUCLEIC ACID; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GENOTYPE; HUMANS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SEX FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84861455911     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2011.8     Document Type: Article

References (58)

1. Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 2004; 1: 27-42.
2. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003; 55: 3-29. (Pubitemid 36078452)
3. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 1771-1775. (Pubitemid 32004809)
4. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22: 336-345. (Pubitemid 29369523)
5. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 2000; 97: 817-822. (Pubitemid 30070393)
6. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 79-83. (Pubitemid 32044523)
7. Ruetz S, Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994; 77: 1071-1081. (Pubitemid 24208866)
8. Lombard-Platet G, Savary S, Sarde CO, Mandel JL, Chimini G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci USA 1996; 93: 1265-1269. (Pubitemid 26052877)
9. Watkins PA, Gould SJ, Smith MA, Braiterman LT, Wei HM, Kok F et al. Altered expression of ALDP in X-linked adrenoleukodystrophy. Am J Hum Genet 1995; 57: 292-301.
10. Kruh GD, Belinsky MG. The MRP family of drug efflux pumps. Oncogene 2003; 22: 7537-7552. (Pubitemid 37487175)
11. Vlaming ML, Lagas JS, Schinkel AH. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 2009; 61: 14-25.
12. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-908. (Pubitemid 26112008)
13. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-238. (Pubitemid 28507666)
14. Kerem BS, Buchanan JA, Durie P, Corey ML, Levison H, Rommens JM et al. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet 1989; 44: 827-834. (Pubitemid 19144441)
15. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 2004; 114: 1343-1353. (Pubitemid 40385306)
16. Slatter TL, Jones GT, Williams MJ, van Rij AM, McCormick SP. Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels. Clin Genet 2008; 73: 179-184.
17. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. Scanning human gene deserts for long-range enhancers. Science 2003; 302: 413. (Pubitemid 37296259)
18. Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M et al. In vivo enhancer analysis of human conserved noncoding sequences. Nature 2006; 444: 499-502. (Pubitemid 44809068)
19. Visel A, Prabhakar S, Akiyama JA, Shoukry M, Lewis KD, Holt A et al. Ultraconservation identifies a small subset of extremely constrained developmental enhancers. Nat Genet 2008; 40: 158-160. (Pubitemid 351171389)
20. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC et al. A genome-wide association study of global gene expression. Nat Genet 2007; 39: 1202-1207. (Pubitemid 47482680)
21. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007; 81: 427-437. (Pubitemid 47330203)
22. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R et al. Genome-wide associations of gene expression variation in humans. PLoS Genet 2005; 1: e78.
23. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C et al. Population genomics of human gene expression. Nat Genet 2007; 39: 1217-1224. (Pubitemid 47482691)
24. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-193. (Pubitemid 36181903)
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
27. Mevik BH, Wehrens R. The pls package: Principal component and partial least squares regression in R. J Stat Softw 2007; 18: 1-24.
28. Williamson DW. Genetic and bioinformatic approaches to identify polymorphic modulators of transcription factor binding and disease phenotypes including HIV-1 viremia. PhD thesis, University of California San Francisco, San Francisco, CA 2008.
29. Tahara H, Yee SW, Urban TJ, Hesselson S, Castro RA, Kawamoto M et al. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5). J Pharmacol Exp Ther 2009; 329: 262-271.
30. Yee SW, Shima JE, Hesselson S, Nguyen L, De Val S, Lafond RJ et al. Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2). J Pharmacol Exp Ther 2009; 328: 699-707.
31. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4: e1000214.
32. van Roermund CW, Visser WF, Ijlst L, van Cruchten A, Boek M, Kulik W et al. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J 2008; 22: 4201-4208.
33. Bahram S, Arnold D, Bresnahan M, Strominger JL, Spies T. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci USA 1991; 88: 10094-10098. (Pubitemid 21915781)
34. Perria CL, Rajamanickam V, Lapinski PE, Raghavan M. Catalytic site modifications of TAP1 and TAP2 and their functional consequences. J Biol Chem 2006; 281: 39839-39851. (Pubitemid 46041787)
35. Bessho Y, Oguri T, Ozasa H, Uemura T, Sakamoto H, Miyazaki M et al. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer. Oncol Rep 2009; 21: 263-268.
36. Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, Kruh GD. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res 2004; 64: 4927-4930. (Pubitemid 38924539)
37. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 2008; 132: 311-322. (Pubitemid 351172431)
38. Sabo PJ, Humbert R, Hawrylycz M, Wallace JC, Dorschner MO, McArthur M et al. Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries. Proc Natl Acad Sci USA 2004; 101: 4537-4542. (Pubitemid 38437446)
39. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120: 169-181. (Pubitemid 40174761)
40. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39: 311-318. (Pubitemid 46328487)
41. Yasuda SU, Zhang L, Huang SM. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther 2008; 84: 417-423.
42. Giacomini KM, Krauss RM, Roden DM, Eichelbaum M, Hayden MR, Nakamura Y. When good drugs go bad. Nature 2007; 446: 975-977. (Pubitemid 46676037)
43. Gamazon ER, Huang RS, Cox NJ, Dolan ME. Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci USA 2010; 107: 9287-9292.
44. Stark AL, Zhang W, Mi S, Duan S, O'Donnell PH, Huang RS et al. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. Pharmacogenomics J 2010; 10: 505-512.
45. Pauli-Magnus C, Meier PJ, Stieger B. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. Semin Liver Dis 2010; 30: 147-159.
46. Funk C, Ponelle C, Scheuermann G, Pantze M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 2001; 59: 627-635. (Pubitemid 32179943)
47. Vaughan AM, Oram JF. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J Biol Chem 2005; 280: 30150-30157. (Pubitemid 41216193)
48. Japan Arteriosclerosis Longitudinal Study (JALS) Group. Japan Arteriosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC): rationale, design, and population characteristics. Circ J 2008; 72: 1563-1568.
49. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
50. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007; 39: 226-231. (Pubitemid 46184354)
51. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, Clark TA et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 2008; 82: 631-640.
52. Storey JD, Madeoy J, Strout JL, Wurfel M, Ronald J, Akey JM. Geneexpression variation within and among human populations. Am J Hum Genet 2007; 80: 502-509.
53. Excoffier L, Hamilton G. Comment on 'Genetic structure of human populations'. Science 2003; 300: 1877; author reply 1877.
54. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA et al. Genetic structure of human populations. Science 2002; 298: 2381-2385. (Pubitemid 36014209)
55. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457: 854-858.
56. Cooper GM, Brown CD. Qualifying the relationship between sequence conservation and molecular function. Genome Res 2008; 18: 201-205. (Pubitemid 351240729)
57. McGaughey DM, Vinton RM, Huynh J, Al-Saif A, Beer MA, McCallion AS. Metrics of sequence constraint overlook regulatory sequences in an exhaustive analysis at phox2b. Genome Res 2008; 18: 252-260. (Pubitemid 351240735)
58. Kim MJ, Skewes-Cox P, Fukushima H, Hesselson S, Nguyen L, Eshragh JL et al. In Vivo pharmacogenomic characterization of enhancers of liver membrane transporters. Clin Pharmacol Ther 2011. (in press).